Novo acquires 10.7% stake in Orexo - MarketLine Financial Deals

Novo acquires 10.7% stake in Orexo

Novo acquires 10.7% stake in Orexo - MarketLine Financial Deals
Novo acquires 10.7% stake in Orexo
Published Apr 07, 2010
3 pages — Published Apr 07, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Novo A/S, a Denmark-based venture capital firm, has acquired a 10.7% stake in Orexo AB, a Sweden-based specialty pharmaceutical company, from Apax Partners LLP and SLS Invest AB

  
Source:
Document ID
MA22201_100331
Country
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Novo acquires 10.7% stake in Orexo" Apr 07, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novo-acquires-10-7-stake-in-Orexo-2052-28238>
  
APA:
MarketLine Financial Deals. (2010). Novo acquires 10.7% stake in Orexo Apr 07, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novo-acquires-10-7-stake-in-Orexo-2052-28238>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.